Group 1 - The core point of the article is that Microgen has become the first company in China to receive approval for the legal sale of allulose, a new food ingredient, by the National Health Commission [1] - The AS10 strain used for the direct fermentation method to produce allulose is the first case in China to be approved for a new food ingredient using synthetic biology technology [1] - Allulose can meet consumer demand for sweetness while not adding metabolic burden, positively impacting blood sugar control and weight management [1] Group 2 - Microgen's first-phase allulose factory in Qinhuangdao has officially commenced production, and the second-phase factory is set to be operational by 2027 [2] - The company is collaborating with traditional bio-manufacturing partners in North China, Northeast China, and Northwest China to advance multiple projects for tens of thousands of tons of production capacity [2] - The compliant sales regions for Microgen's allulose now cover multiple countries and regions, including Asia-Pacific and North America, impacting a total population of approximately 2 billion people [2]